| P2093 | author name string | Kamanna VS | |
| | Kashyap ML | |
| P2860 | cites work | A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism | Q24646308 |
| | Identification of scavenger receptor SR-BI as a high density lipoprotein receptor | Q28273182 |
| | Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B | Q28625242 |
| | Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition | Q28625661 |
| | Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 |
| | Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol | Q32068503 |
| | Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 |
| | Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons | Q34056613 |
| | Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells | Q34128848 |
| | Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 |
| | Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells | Q36683551 |
| | Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism | Q37038074 |
| | High Density Lipoprotein Metabolism in Man | Q37047273 |
| | An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells | Q37278800 |
| | Basic considerations in the reversal of atherosclerosis: significance of high-density lipoprotein in stimulating reverse cholesterol transport | Q38617105 |
| | The pathogenesis of atherosclerosis--an update | Q39726917 |
| | Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins | Q40160281 |
| | Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein | Q40343323 |
| | Molecular physiology of reverse cholesterol transport | Q40526401 |
| | Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk | Q40594848 |
| | Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. | Q40851335 |
| | A docking receptor for HDL cholesterol esters | Q40944548 |
| | Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture | Q41006869 |
| | Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models | Q41119433 |
| | High density lipoprotein and lipoprotein oxidation. | Q41119449 |
| | Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. | Q41164669 |
| | Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge | Q41173078 |
| | In HepG2 cells, translocation, not degradation, determines the fate of the de novo synthesized apolipoprotein B. | Q41267533 |
| | Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester | Q41473085 |
| | Atherogenic lipoproteins and human disease: extending concepts beyond the heart to the kidney | Q41571002 |
| | Effects of lipid lowering therapy on progression of coronary and carotid artery disease | Q41669486 |
| | Role of cholesterol ester mass in regulation of secretion of ApoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship | Q42468943 |
| | Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5'-flanking region of the human ApoA-I gene. | Q42801250 |
| | Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII | Q44208764 |
| | Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). | Q45208371 |
| | Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels | Q45881945 |
| | Mechanistic studies of high-density lipoproteins | Q46542322 |
| | Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. | Q46734243 |
| | High density associated enzymes: their role in vascular biology | Q46928300 |
| | Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies | Q47915012 |
| | Protein composition determines the anti-atherogenic properties of HDL in transgenic mice | Q59064040 |
| | Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells | Q67926118 |
| | Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells | Q69361623 |
| | Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion | Q69447815 |
| | Pulse-chase studies of the synthesis and intracellular transport of apolipoprotein B-100 in Hep G2 cells | Q70148161 |
| | Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles | Q70164761 |
| | Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man | Q70731976 |
| | Synthesis and secretion of apolipoprotein B from cultured liver cells | Q70785454 |
| | High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules | Q71799260 |
| | Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex | Q72216875 |
| | Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells | Q72571322 |
| | Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport | Q73832914 |
| | Studies on the Effect of Nicotinic Acid on Catecholamine Stimulated Lipolysis in Adipose Tissue in Vitro | Q76461403 |
| | Endothelium and acute coronary syndromes | Q77086221 |
| | Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells | Q77297680 |
| | Lipoprotein classes and coronary disease regression | Q77306690 |
| | Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density | Q77342521 |
| | Regulation of the assembly and secretion of very low density lipoproteins by the liver | Q77477177 |
| | Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice | Q77604676 |
| | Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene | Q77801094 |
| | State-of-the-art update and review: clinical trials of lipid-lowering agents | Q77896411 |
| | Some insulin-like effects of nicotinic acid observed with isolated rat epididymal adipose tissue | Q79056517 |
| P433 | issue | 1 | |
| P921 | main subject | lipoprotein | Q28350 |
| | niacinamide | Q192423 |
| P304 | page(s) | 36-46 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
| P1476 | title | Mechanism of action of niacin on lipoprotein metabolism | |
| P478 | volume | 2 | |